Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multi-pathway neuroprotective effects of a novel salidroside derivative SHPL-49 against acute cerebral ischemic injury
Pei Zhang, Jiazhen Xu, Qianfei Cui, et al.
European Journal of Pharmacology (2023) Vol. 949, pp. 175716-175716
Open Access | Times Cited: 13

Showing 13 citing articles:

Chiral drugs: Sources, absolute configuration identification, pharmacological applications, and future research trends
Shoujiao Peng, Yuying Zhu, Chunying Luo, et al.
LabMed discovery. (2024) Vol. 1, Iss. 1, pp. 100008-100008
Open Access | Times Cited: 10
Neuroprotective effects of the salidroside derivative SHPL-49 via the BDNF/TrkB/Gap43 pathway in rats with cerebral ischemia
Suxin You, Zhouyun Ma, Pei Zhang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116460-116460
Open Access | Times Cited: 8
Salidroside derivative SHPL-49 attenuates glutamate excitotoxicity in acute ischemic stroke via promoting NR2A-CAMKⅡα-Akt /CREB pathway
Dong Xie, Pei Zhang, Suxin You, et al.
Phytomedicine (2024) Vol. 134, pp. 155583-155583
Open Access | Times Cited: 5
Salidroside inhibits renal ischemia/reperfusion injury‑induced ferroptosis by the PI3K/AKT signaling pathway
Zhe Tang, Yong Wang, Yan Liu, et al.
Experimental and Therapeutic Medicine (2023) Vol. 26, Iss. 5
Open Access | Times Cited: 12
Salidroside attenuates cognitive deficits induced by chronic cerebral hypoperfusion via modulating microglial phenotypic transformation in mice
Weiwei Ji, Zengyu Zhang, Ting Jin, et al.
Journal of Neuroimmunology (2025) Vol. 400, pp. 578544-578544
Closed Access
Nephroprotective effects of substances of medicine food homology and traditional Chinese medicine phytochemicals against acute kidney injury
Ling Chen, Yanyan Deng, Jing Hu, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Salidroside Derivative SHPL-49 Exerts Anti-Neuroinflammatory Effects by Modulating Excessive Autophagy in Microglia
Zhirui Zheng, Ruyi Wang, Yu Zhao, et al.
Cells (2025) Vol. 14, Iss. 6, pp. 425-425
Open Access
From Synaptic Plasticity to Neurodegeneration: BDNF as a Transformative Target in Medicine
Corneliu Toader, Matei Serban, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4271-4271
Open Access
Natural herbal extract roles and mechanisms in treating cerebral ischemia: A systematic review
Jiashuo Yang, Bo Yu, Jian Zheng
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Targeting astrocytes polarization after spinal cord injury: a promising direction
Helin Li, Ying Liu, Yuxiang Sun, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Microglia-mediated endothelial protection: the role of SHPL-49 in ischemic stroke
Yu Zhao, Pei Zhang, Jiange Zhang
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117530-117530
Open Access | Times Cited: 2
First-in-human study to assess the safety, tolerability, and pharmacokinetics of intravenous SHPL-49 following single- and multiple-ascending-dose administration in healthy adults
Shuya Li, Cuicui Yang, Weicong Wang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 249, pp. 116314-116314
Closed Access
Salidroside Derivative SHPL-49 Attenuates Glutamate Excitotoxicity in Acute Ischemic Stroke Via Promoting NR2A-CAMKⅡα-Akt /CREB Pathway
Dong Xie, Pei Zhang, Suxin You, et al.
(2023)
Closed Access
Page 1

Scroll to top